Elanco Animal Health (ELAN) Total Debt (2018 - 2026)
Elanco Animal Health (ELAN) reported Total Debt of $3.8 billion for Q1 2026, down 13.33% on a YoY basis from $4.4 billion in Q1 2025, and down 0.7% sequentially from $3.8 billion in Q4 2025.
Elanco Animal Health (ELAN) Total Debt (2018 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 9 years of Total Debt data on file, last reported at $3.8 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Debt fell 13.33% year-over-year to $3.8 billion; the trailing twelve-month figure through Mar 2026 stood at $3.8 billion (down 13.33% YoY), and the FY2025 full-year result was $3.8 billion, down 11.22% from the prior year.
- Total Debt slipped to $3.8 billion in Q1 2026, from $3.8 billion in the prior quarter.
- In the past five years, Total Debt ranged from a high of $6.3 billion in Q3 2022 to a low of $3.8 billion in Q1 2026.
- A 5-year average of $5.1 billion and a median of $5.8 billion in 2024 frame the typical range for Total Debt.
- Across the five-year window, Total Debt increased 0.63% in 2023 and retreated 25.68% in 2024, its largest moves.
- Tracing ELAN's Total Debt over 5 years: stood at $5.8 billion in 2022, then declined by 0.41% to $5.8 billion in 2023, then dropped by 25.65% to $4.3 billion in 2024, then declined by 11.22% to $3.8 billion in 2025, then fell by 0.7% to $3.8 billion in 2026.
- Business Quant data shows ELAN's Total Debt at $3.8 billion in Q1 2026, $3.8 billion in Q4 2025, and $4.0 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 198.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.81 Bn |
| Dec 31, 2025 | 3.84 Bn |
| Sep 30, 2025 | 4.02 Bn |
| Jun 30, 2025 | 4.21 Bn |
| Mar 31, 2025 | 4.40 Bn |
| Dec 31, 2024 | 4.32 Bn |
| Sep 30, 2024 | 4.40 Bn |
| Jun 30, 2024 | 4.53 Bn |
| Mar 31, 2024 | 5.77 Bn |
| Dec 31, 2023 | 5.81 Bn |
| Sep 30, 2023 | 5.91 Bn |
| Jun 30, 2023 | 6.10 Bn |
| Mar 31, 2023 | 6.02 Bn |
| Dec 31, 2022 | 5.84 Bn |
| Sep 30, 2022 | 6.30 Bn |
| Jun 30, 2022 | 6.06 Bn |
| Mar 31, 2022 | 6.20 Bn |
| Dec 31, 2021 | 6.61 Bn |
| Sep 30, 2021 | 6.40 Bn |
| Jun 30, 2021 | 6.65 Bn |